INTRODUCTION
Spina bifida, and the related neural tube defects of anencephaly and encephalocoele, are major causes of perinatal, infant and childhood mortality and morbidity. Mid-trimester screening for neural tube defects by maternal serum a-fetoprotein estimation or fetal ultrasound examination can identify over 80% of affected pregancies, and identification is usually followed by termination of pregnancy. While such screening on a population basis has led to a fall in the birth prevalence of neural tube defects 2 , 3, it has not prevented the development of these defects in early pregnancy or the parental griefassociated with having an affected pregnancy.
PREVENTION OF NEURAL TUBE DEFECTS BY PERICONCEPTIONAL FOLATE
There is now firm evidence that the majority of neural tube defects can be prevented by an adequate intake of periconceptional folate, a B group vitamin found especially in leafy green vegetables, some other vegetables and fruits, and wholegrain cereals. Although maternal nutrition had been suspected as a risk factor for neural tube defects for a long time, the publication of a trial of periconceptional multivitamin supplementation in 1980 4 prompted renewed and widespread research interest in the topic. A particular emphasis in this research was on the role of folate. A summary of studies published over the last 15 years is presented in Table 1 . All studies (case-control and cohort studies, non-randomized and randomized controlled trials)4--18 showed a reduction in risk with increased intake of either dietary or supplemental folate, and many were individually statistically significant. The two large randomized controlled trials provided the most conclusive evidence that folate prevents neural tube defects I2,14,15. In the Medical Research Council (MRC) multi centre trial I 2 , women who had previously had an infant with a neural tube defect and, hence, were at increased risk of TVW Telethon Institute for Child Health Research, PO Box 855, West Perth 6872,
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Correspondence to: Dr C Bower another affected pregnancy, were randomly allocated to one of four groups to investigate the effect of both folic acid (4 mg per day) and a mixture of other vitamins; the design was factorial. Supplementation with folic acid prevented 71% of recurrent neural tube defects (relative risk 0.29, 95% confidence interval 0.10-0.74). No significant reduction in risk was found in the group of women who received the multivitamin mixture (relative risk 0.8, 95% confidence interval O. 38~1.70, P=0.7). In the second trial, conducted in Hungaryl4, women planning their first pregnancy were randomly allocated to receive either a trace element supplement or a multivitamin supplement containing 0.8 mg folic acid daily. In the final report of this trial 1S , there were six infants reported with neural tube defects born to 2471 women allocated to receive the trace element supplement, and none to the 2391 women allocated to the multivitamin group (95% confidence interval 0-0.88, P=O.034).
Although there are group differences in folate status between women who have and do not have an affected pregnancy, there is at present no way to identify individual women at risk by measuring their folate intake or their blood levels of folate!". In a study of 81 women with an affected pregnancy, only seven had a serum folate level in the deficient range, and only 11 had a red cell folate level in the deficient range 20 . For this reason, all women of childbearing age and capable of becoming pregnant must be targeted. The minimum fully effective amount of folic acid needed to prevent neural tube defects may never be determined but, from the published studies, modest increases in dietary folate reduce the risk of neural tube defects 7 , 16, 17, as do folic acid supplements of between 0.36mg and 5 mg daily!". The challenge is to ensure that woman of childbearing age are aware that an increase in folate consumption before and in early pregnancy will help to prevent neural tube defects, and are encouraged to increase their consumption. This requires education of both health professionals and the public.
NATIONAL RECOMMENDATIONS FOR

INCR~ASING
PERICONCEPTIONAL FOLATE
Folate intake can be increased in three complementary ways: by taking a folic acid supplement; by eating folate-rich foods; and by eating foods fortified with folate. National bodies in several countries have issued recommendations about folate to prevent neural tube defects 21-28 ( Table 2) . All have recommended a combination of dietary and supplemental means to increase periconceptional folate intake, and most have recommended fortification of food with folic acid. In the UK, in December 1992, the Chief Medical Officers and the Chief Nursing Officers of the Department of Health sent a letter to all doctors in the country, along with a copy of the recommendations of the Expert Advisory Group-'. The Department of Health and the Association for Spina Bifida and Hydrocephalus have produced pamphlets for women, and several local initiatives have been undertaken to promote folate to women of childbearing age. The Department of Health has recently allocated funds to further improve knowledge in the UK about folate and neural tube defects prevention. An increasing number of breads and cereals are fortified with folic acid in the UK29, and there is currently discussion on whether to make fortification mandatory.
In the USA, National and State initiatives have been developed 30,31. The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), while accepting the need for fortification as a public health measure, are debating the level of fortification, with the FDA recommending up to 140Jlg/100g flour and the CDC 350 Jlg/100 g f1our32,33 . Fortification will be mandatory from 1 January 1998.
In Australia, three states have undertaken health promotion campaigns to inform health professionals and women about folate and the prevention of neural tube defects. Fortification of food with folic acid had not been allowed in Australia until the National Standard A9 on Vitamins and Minerals was revised and accepted in June 1995. Voluntary fortification of flour, bread, savoury biscuits, breakfast cereals, pasta, fruit and vegetable juices and yeast extracts is now permitted, to levels of 100Jig per reference quantity of these foods. The reference quantity for flour is 35g, for bread 50 g, for dry pasta 35 g, and for juices 200 mJ34. Given the lack of experience in Australia with folate fortification, it is likely to be some time before a wide range of fortified products reach the supermarket shelves-'. An economic analysis has demonstrated that, by preventing neural tube defects, compulsory folic acid fortification of grain in the USA might yield a substantial economic benefit.". Concern has been voiced about compulsory fortification in the USA37 and in the UK38, and it is not clear how effective voluntary fortification measures might be 39. Manufacturers may see no market advantage to fortifying their products; or perhaps only premium products would be fortified, thus defeating the purpose of fortification in providing a means to reach all women of childbearing age.
EFFECTIVENESS OF RECOMMENDATIONS
Little has been published on details of the public health initiatives which have been undertaken, and there have been no population-based data reported which show a reduction in neural tube defects as a result of public health measures to promote folate consumption in women of childbearing age. A survey in 1994 of 123 women attending genetic clinics in Canada revealed that only 18% were aware of the association between folate and the prevention of neural tube defects and, even amongst women who had an infant with a neural tube defect in their family, only 37% were aware of the association'". After 2 years of a government education programme in the UK, a survey of 194 mothers of babies born in 1994 revealed that 33% of mothers had not heard of folate, and 81% did not know about the recommendation for supplementation before pregnancy52. A national telephone survey of 2010 American women aged between 18 and 45 years, conducted in early 1995 in the USA, found that 15% of women were aware of the recommendation that women of childbearing age should consume 0.4mg folic acid daily, although only 5% thought the reason for this was to prevent birth defects or spina bifida s3. In the Netherlands, 135 of 485 women surveyed (27.8%) had heard of folic acid, and 75 (15.5%) mentioned that folic acid helped prevent birth defects. Only 10 women had obtained this information from a general practitioner, midwife or pharmacisr'".
PROBLEMS WITH INCREASING FOLATE INTAKE
It is disappointing that there has been such a slow reaction to an effective nutritional means of preventing neural tube defects. Some of this delay has been because of the debate about the best way to increase periconceptional folate intake. There is a belief that attempting to influence dietary intake is not generally successful, although this is not necessarily the case 54. As not all pregnancies are planned, periconceptional supplementation with folic acid is not possible, unless all women capable of becoming pregnant take a supplement for their entire fertile life. Thus, food fortification may be the most effective means of reaching the majority of women, whether they are planning a pregnancy or not, and without necessitating a change in eating behaviour 20 , 55,56. However, concern has been expressed because fortification would affect the whole population, not just the target group of childbearing age. Since we do not know what the effect on certain subgroups of the population might be, some have recommended that data be gathered on these subgroups in order to develop an informed and coherent long-term policy57, One of the subgroups is persons taking anticonvulsant drugs, who may have reduced seizure control in the presence of increased folate. Such an effect has been observed with high doses of folic acid58, but several randomized controlled trials have not shown an effect of oral folic acid on seizure control at doses up to 20 mg a d ay 59-61. Other concerns relate to persons taking medications with antifolate effects, such as methotrexate, and the effect of folate on zinc metabolism'<. However, the major concern is that persons who have untreated vitamin B12 deficiency may develop neuropathy in the absence of an anaemia, which may become irreversible before the diagnosis of B 12 deficiency is made. This is unlikely, given that the diagnosis of B 12 deficiency is now based on B 12 measurement rather than on the presence of a macrocytic anaemia 29 ,63,64, and patients can be vitamin B 12 deficient (with or without neuropathy) and not have a macrocytic anaemia 65 -67 . Few people in the population are likely to have an intake of folate from fortified food high enough to constitute a hazard in the above situations but, if fortification is undertaken, it will be important to monitor intakes, particularly in these groups.
PREVENTION OF OTHER BIRTH DEFECTS WITH PERICONCEPTIONAL FOLATE
There is emerging evidence that several other birth defects may also be prevented by increased peri conceptional folate 68 -73 (Table 4- ). There are several other suggested benefits of increased folic acid intake (such as preventing or treating precancerous lesions of the cervix 74 and the bron-chus7S, primitive neuroectodermal tumours in children 76, and cardiovascular disease 77 ) . Whilst this evidence for additional benefit is at present uncertain, it tends to support programmes aimed at increasing population folate intake.
MECHANISM OF ACTION OF FOLIC ACID
The underlying mechanism(s) of action of folic acid in preventing neural tube defects is not known. There were similar rates of miscarriage in women in the folic acid and control groups of the MRC Vitamin Stud y 12 and of the Hungarian trial! S, so it is unlikely that folic acid induces the early loss of fetuses with neural tube defects. Folic acid is also unlikely to prevent neural tube defects for which there is another known cause, for example the autosomal recessive Meckel syndrome, or a chromosomal anomaly. The serum folic acid levels were high in those women in the MRC Vitamin Stud y l 2 who were supplemented with folic acid but still had an affected infant, so the lack of a protective effect was not due to failure to take the folic acid supplement or to absorb it. There is evidence from a study in Dublin that vitamin B 12 and folic acid are independent risk factors for neural tube defects78.
A genetic abnormality of folate metabolism was suggested as the underlying abnormality some time ag0 79 and more recent research has supported this 78 ,8o-86. Because of the independent effects of folate and vitamin B 12 , Kirke et aI. 78 suggested that the enzyme methionine synthase may be involved in the aetiology of neural tube defects, and further work by this group of researchers demonstrated an abnormality in homocysteine metabolism, apparently related to methionine synthase'". Other researchers have postulated a defect in another enzyme in the metabolic pathway of folate, 5,10-methylenetetrahydrofolate reductases-, and a recent Dutch study identified 13% of patients with spina bifida, 16% of their mothers and 10% of their fathers as homozygous for a mutation in the gene coding of this enzyme, compared with only 5% of controls 88 . However, other studies have had a higher prevalence of the mutation in controls'", so there is still some debate whether this mutation should be regarded as a genetic risk factor for some instances of spina bifida. It is plausible that many genetic abnormalities in folate metabolism lead to failure of the neural tube to close, and some (or all) of them may be circumvented by increased folate. Further research may also identify risk factors for those neural tube defects not preventable by folate, and confirm whether other birth defects are prevented by folate.
CONCLUSIONS
While this research IS under way, and while debate continues about the best method for prevention, babies with neural tube defects will continue to be born unless preventive strategies are undertaken Simultaneously. As Bradford Hill said in 1965, All scientific work is liable to be upset or modified by advancing knowledge. That does not confer upon us a freedom to ignore the knowledge we already have, or to postpone the action it appears to demand at a given time'", We must not lose sight of the fact that most neural tube defects can be prevented right now if women consume sufficient folic acid periconceptionally. Raising public and professional awareness is a public health imperative. 10 
